Temporin-1DRa

General Information


DRACP ID  DRACP02067

Peptide Name   Temporin-1DRa

Sequence  HFLGTLVNLAKKIL

Sequence Length  14

UniProt ID  M9NXM1 

PubChem CID  Not available

Origin  Rana draytonii

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma LC50=45 µM CytoTox 96 non-radiactive cytotoxicity assay  1 h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=65 µM

Normal (non-cancerous) Cytotoxicity  Mouse fibroblasts L929: LC50=18 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02067

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  X=AIB (Aminoisobutyric acid)

Chiral  L



Physicochemical Information


Formula  C75H127N19O17

Absent amino acids  CDEMPQRSWY

Common amino acids  L

Mass  179903

Pl  10.81

Basic residues  3

Acidic residues  0

Hydrophobic residues  8

Net charge  3

Boman Index  940

Hydrophobicity  92.14

Aliphatic Index  167.14

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17767978

Title  Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa

Doi 10.1016/j.peptides.2007.07.023

Year  2007

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_2335

DRACP is developed by Dr.Zheng's team.